Tag: RADIANCE-II
Money-maker or meritable: Is renal denervation out of retirement?
In a paper published in the July 2024 issue of the Journal of Hypertension, Andrew Sharp (University...
ReCor Medical announces consistent reduction of blood pressure in pooled analysis of three clinical trials at AHA 2022
ReCor Medical and its parent company, Otsuka Medical Devices, announced consistent and significa...
TCT 2022 hears “important data” from renal denervation trials
Findings from the RADIANCE II randomised pivotal trial, presented at the 2022 Transcatheter Card...
FDA approves RADIANCE-II study of Paradise ultrasound denervation system
The RADIANCE-II study of the Paradise Ultrasound Denervation System (ReCor Medical) for the trea...
